Literature DB >> 16754264

Toward a clinically-oriented model of anxiety disorders.

Peter J Norton1.   

Abstract

The Diagnostic and Statistical Manual of Mental Disorders (DSM) model of psychopathology has generally been the accepted standard in North America for understanding and diagnosing psychological disorders for over half a century. This classification model, particularly since DSM-III, has been formulated around the goals of aiding diagnosis, enhancing communication among professionals, fostering psychopathology research and informing treatment. However, all classification systems are inherently dependent on the purpose for the classification. In this paper, an argument is made for a clinically-relevant diagnostic system of mental disorders to support a primary goal of informing treatment. Several lines of research are examined, including studies on diagnostic reliability, dimensional vs categorical nature of anxiety disorders, co-morbidity, and psychotherapeutic and pharmacological treatment outcome as they relate to current and proposed diagnostic models of anxiety disorders. Based on the evidence, suggestions are made for revising diagnostic models of anxiety, and key lines of future research are proposed.

Entities:  

Mesh:

Year:  2006        PMID: 16754264     DOI: 10.1080/16506070500441561

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  8 in total

1.  A randomized clinical trial of transdiagnostic cognitve-behavioral treatments for anxiety disorder by comparison to relaxation training.

Authors:  Peter J Norton
Journal:  Behav Ther       Date:  2011-05-25

2.  Smoking Behavior and Alcohol Consumption in Individuals With Panic Attacks.

Authors:  Amanda R Mathew; Peter J Norton; Michael J Zvolensky; Julia D Buckner; Jasper A J Smits
Journal:  J Cogn Psychother       Date:  2011-02-01

3.  Transdiagnostic versus diagnosis-specific cbt for anxiety disorders: a preliminary randomized controlled noninferiority trial.

Authors:  Peter J Norton; Terri L Barrera
Journal:  Depress Anxiety       Date:  2012-07-05       Impact factor: 6.505

4.  Associations among anxiety, self-efficacy, and self-care in rural adolescents with poorly controlled asthma.

Authors:  Eleanor R Turi; Laura C Reigada; Jianfang Liu; Sarah I Leonard; Jean-Marie Bruzzese
Journal:  Ann Allergy Asthma Immunol       Date:  2021-09-20       Impact factor: 6.347

5.  A qualitative study of the feasibility and acceptability of a smoking cessation program for people living with HIV and emotional dysregulation.

Authors:  A K Labbe; J G Wilner; J N Coleman; S M Marquez; J D Kosiba; M J Zvolensky; J A J Smits; P J Norton; D Rosenfield; C O'Cleirigh
Journal:  AIDS Care       Date:  2018-10-23

6.  Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder.

Authors:  Yves Lecrubier; Ornah T Dolberg; Henning F Andersen; Emmauelle Weiller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

7.  Short-term intensive psychodynamic group therapy versus cognitive-behavioral group therapy in day treatment of anxiety disorders and comorbid depressive or personality disorders: study protocol for a randomized controlled trial.

Authors:  Hubert Suszek; Paweł Holas; Tomasz Wyrzykowski; Steinar Lorentzen; Andrzej Kokoszka
Journal:  Trials       Date:  2015-07-29       Impact factor: 2.279

8.  A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.

Authors:  Pasquale Roberge; Martin D Provencher; Patrick Gosselin; Helen-Maria Vasiliadis; Isabelle Gaboury; Annie Benoit; Martin M Antony; Nils Chaillet; Janie Houle; Catherine Hudon; Peter J Norton
Journal:  BMC Psychiatry       Date:  2018-10-03       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.